Company
Headquarters: White Plains, NY, United States
Employees: 16
CEO: Ms. Monique P. Fayad M.B.A.
£2.5 Million
GBP as of July 1, 2024
US$3.2 Million
Company | Market Cap (USD) |
---|---|
GE HealthCare | $35.26 B |
Veeva Systems Inc. | $29.31 B |
Change Healthcare Inc. | $9.03 B |
Pro Medicus Limited | $8.96 B |
Signify Health, Inc. | $8.38 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Trellus Health plc has the following listings and related stock indices.
Stock: LSE: TRLS wb_incandescent